Click for best price
Postpemic Era LongActing Injectables Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global Long-Acting Injectables Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Long-Acting Injectables industry at home and abroad, estimate the overall market scale of the Long-Acting Injectables industry and the market share of major countries, Long-Acting Injectables industry, and study and judge the downstream market demand of Long-Acting Injectables through systematic research, Analyze the competition pattern of Long-Acting Injectables, so as to help solve the pain points of various stakeholders in Long-Acting Injectables industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Long-Acting Injectables Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Long-Acting Injectables Market?
Eli Lilly
Pfizer
GlaxoSmithKline
Johnson & Johnson
Lupin
Zogenix
DURECT
Medincel
Major Type of Long-Acting Injectables Covered in XYZResearch report:
Small and Middle Sized Molecule
Large Sized Molecule
Application Segments Covered in XYZResearch Market
Schizophrenia
Other Psychotic Disorders
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Long-Acting Injectables Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
86 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Long-Acting Injectables Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Long-Acting Injectables Market by Value
2.2.1 Global Long-Acting Injectables Revenue by Type
2.2.2 Global Long-Acting Injectables Market by Value
2.3 Global Long-Acting Injectables Market by Sales
2.3.1 Global Long-Acting Injectables Sales by Type
2.3.2 Global Long-Acting Injectables Market by Sales
3. The Major Driver of Long-Acting Injectables Industry
3.1 Historical & Forecast Global Long-Acting Injectables Sales and Revenue (2018-2028)
3.2 Largest Application for Long-Acting Injectables (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Long-Acting Injectables Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Long-Acting Injectables Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Long-Acting Injectables Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Long-Acting Injectables Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Long-Acting Injectables Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Long-Acting Injectables Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Long-Acting Injectables Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Long-Acting Injectables Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Long-Acting Injectables Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Long-Acting Injectables Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Long-Acting Injectables Average Price Trend
13.1 Market Price for Each Type of Long-Acting Injectables in US (2018-2022)
13.2 Market Price for Each Type of Long-Acting Injectables in Europe (2018-2022)
13.3 Market Price for Each Type of Long-Acting Injectables in China (2018-2022)
13.4 Market Price for Each Type of Long-Acting Injectables in Japan (2018-2022)
13.5 Market Price for Each Type of Long-Acting Injectables in India (2018-2022)
13.6 Market Price for Each Type of Long-Acting Injectables in Korea (2018-2022)
13.7 Market Price for Each Type of Long-Acting Injectables in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Long-Acting Injectables in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Long-Acting Injectables Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Long-Acting Injectables
15. Long-Acting Injectables Competitive Landscape
15.1 Eli Lilly
15.1.1 Eli Lilly Company Profiles
15.1.2 Eli Lilly Product Introduction
15.1.3 Eli Lilly Long-Acting Injectables Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Pfizer
15.2.1 Pfizer Company Profiles
15.2.2 Pfizer Product Introduction
15.2.3 Pfizer Long-Acting Injectables Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 GlaxoSmithKline
15.3.1 GlaxoSmithKline Company Profiles
15.3.2 GlaxoSmithKline Product Introduction
15.3.3 GlaxoSmithKline Long-Acting Injectables Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Johnson & Johnson
15.4.1 Johnson & Johnson Company Profiles
15.4.2 Johnson & Johnson Product Introduction
15.4.3 Johnson & Johnson Long-Acting Injectables Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Lupin
15.5.1 Lupin Company Profiles
15.5.2 Lupin Product Introduction
15.5.3 Lupin Long-Acting Injectables Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Zogenix
15.6.1 Zogenix Company Profiles
15.6.2 Zogenix Product Introduction
15.6.3 Zogenix Long-Acting Injectables Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 DURECT
15.7.1 DURECT Company Profiles
15.7.2 DURECT Product Introduction
15.7.3 DURECT Long-Acting Injectables Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Medincel
15.8.1 Medincel Company Profiles
15.8.2 Medincel Product Introduction
15.8.3 Medincel Long-Acting Injectables Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Long-Acting Injectables Industry (Volume)
Figure 2. Long-Acting Injectables Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Long-Acting Injectables Revenue in 2022
Figure 5. US Long-Acting Injectables Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Long-Acting Injectables Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Long-Acting Injectables Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Long-Acting Injectables Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Long-Acting Injectables Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Long-Acting Injectables Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Long-Acting Injectables Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Long-Acting Injectables Revenue, by Type (Million USD) (2018-2028)
Table 4. Long-Acting Injectables Sales, by Type (K Unit) (2018-2028)
Table 5. Long-Acting Injectables Sales (K Unit) by Application (2018-2028)
Table 6. Long-Acting Injectables Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Long-Acting Injectables Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Long-Acting Injectables Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Long-Acting Injectables Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Long-Acting Injectables Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Long-Acting Injectables Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Long-Acting Injectables Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Long-Acting Injectables Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Long-Acting Injectables Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Long-Acting Injectables in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Long-Acting Injectables in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Long-Acting Injectables in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Long-Acting Injectables in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Long-Acting Injectables in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Long-Acting Injectables in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Long-Acting Injectables in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Eli Lilly Profiles
Table 61. Eli Lilly Long-Acting Injectables Product Introduction
Table 62. Eli Lilly Long-Acting Injectables Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Eli Lilly Strategic initiatives
Table 64. Pfizer Profiles
Table 65. Pfizer Long-Acting Injectables Product Introduction
Table 66. Pfizer Long-Acting Injectables Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Pfizer Strategic initiatives
Table 68. GlaxoSmithKline Profiles
Table 69. GlaxoSmithKline Long-Acting Injectables Product Introduction
Table 70. GlaxoSmithKline Long-Acting Injectables Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. GlaxoSmithKline Strategic initiatives
Table 72. Johnson & Johnson Profiles
Table 73. Johnson & Johnson Long-Acting Injectables Product Introduction
Table 74. Johnson & Johnson Long-Acting Injectables Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Johnson & Johnson Strategic initiatives
Table 76. Lupin Profiles
Table 77. Lupin Long-Acting Injectables Product Introduction
Table 78. Lupin Long-Acting Injectables Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Lupin Strategic initiatives
Table 80. Zogenix Profiles
Table 81. Zogenix Long-Acting Injectables Product Introduction
Table 82. Zogenix Long-Acting Injectables Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Zogenix Strategic initiatives
Table 84. DURECT Profiles
Table 85. DURECT Long-Acting Injectables Product Introduction
Table 86. DURECT Long-Acting Injectables Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. DURECT Strategic initiatives
Table 88. Medincel Profiles
Table 89. Medincel Long-Acting Injectables Product Introduction
Table 90. Medincel Long-Acting Injectables Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Medincel Strategic initiatives
